Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic Management

The management of rheumatoid arthritis (RA) has undergone several practice-defining evolutions, beginning with the approval of low-dose methotrexate and continuing through the introduction of numerous disease-modifying antirheumatic drugs (DMARDs). With increasing capability to target pro-inflammato...

Description complète

Détails bibliographiques

Auteurs principaux:	Joshua J. Skydel, Betty Hsiao
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2026-01-01
Collection:	Pharmaceuticals
Sujets:	rheumatoid arthritis DMARD treat-to-target difficult-to-treat phenotyping precision medicine
Accès en ligne:	https://www.mdpi.com/1424-8247/19/2/218
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!